Does tumour dormancy offer a therapeutic target?

被引：250

作者：

Goss, Paul E. ^{[3
]}

Chambers, Ann F. ^{[1
,2
]}

机构：

[1] Univ Western Ontario, London Reg Canc Program, London, ON N6A 4L6, Canada

[2] Univ Western Ontario, Dept Oncol, London, ON N6A 4L6, Canada

[3] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA

来源：

NATURE REVIEWS CANCER | 2010年 / 10卷 / 12期

关键词：

ADJUVANT TAMOXIFEN THERAPY; MINIMAL RESIDUAL DISEASE; MAMMARY-CARCINOMA CELLS; BREAST-CANCER PATIENTS; RANDOMIZED-TRIAL; BONE-MARROW; METASTATIC OUTGROWTH; POSTMENOPAUSAL WOMEN; PREMENOPAUSAL WOMEN; UPDATED FINDINGS;

D O I：

10.1038/nrc2933

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The increasing number of cancer survivors is cause for celebration, but this expanding population has highlighted the problem of tumour dormancy, which can lead to relapse. As we start to understand more about the biology of dormant cancer cells, we can begin to address how best to treat this form of disease. Preclinical models and initial clinical trials, as exemplified in patients with breast cancer, are paving the way to address how best to treat long-term cancer survivors to minimize the risk of cancer recurrence.

引用

页码：871 / 877

页数：7

共 72 条

[61] Integrin β1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs [J].

Shibue, Tsukasa ;

Weinberg, Robert A. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (25) :10290-10295

[62] Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment [J].

Slade, M. J. ;

Payne, R. ;

Riethdorf, S. ;

Ward, B. ;

Zaidi, S. A. A. ;

Stebbing, J. ;

Palmieri, C. ;

Sinnett, H. D. ;

Kulinskaya, E. ;

Pitfield, T. ;

McCormack, R. T. ;

Pantel, K. ;

Coombes, R. C. .

BRITISH JOURNAL OF CANCER, 2009, 100 (01) :160-166

[63] Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast cancer [J].

Stewart, HJ ;

Forrest, AP ;

Everington, D ;

McDonald, CC ;

Dewar, JA ;

Hawkins, RA ;

Prescott, RJ ;

George, WD .

BRITISH JOURNAL OF CANCER, 1996, 74 (02) :297-299

[64] Dormant cancer cells retrieved from metastasis-free organs regain tumorigenic and metastatic potency [J].

Suzuki, Mika ;

Mose, Evangeline Sari ;

Montel, Valerie ;

Tarin, David .

AMERICAN JOURNAL OF PATHOLOGY, 2006, 169 (02) :673-681

[65] Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer [J].

Tormey, DC ;

Gray, R ;

Falkson, HC .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (24) :1828-1833

[66] Three-Dimensional Imaging and Quantification of Both Solitary Cells and Metastases in Whole Mouse Liver by Magnetic Resonance Imaging [J].

Townson, Jason L. ;

Ramadan, Soha S. ;

Simedrea, Carmen ;

Rutt, Brian K. ;

MacDonald, Ian C. ;

Foster, Paula J. ;

Chambers, Ann F. .

CANCER RESEARCH, 2009, 69 (21) :8326-8331

[67]

Tsao HS, 1997, CANCER, V79, P2361

[68]

Weiss L, 1990, Adv Cancer Res, V54, P159, DOI 10.1016/S0065-230X(08)60811-8

[69] Assessment of quality of life in MA.17: A randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women [J].

Whelan, TJ ;

Goss, PE ;

Ingle, JN ;

Pater, JL ;

Tu, DS ;

Pritchard, K ;

Liu, SF ;

Shepherd, LE ;

Palmer, M ;

Robert, NJ ;

Martino, S ;

Muss, HB .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) :6931-6940

[70] Cancer micrometastasis and tumour dormancy [J].

Wikman, Harriet ;

Vessella, Robert ;

Pantel, Klaus .

APMIS, 2008, 116 (7-8) :754-770

← 1 2 3 4 5 6 7 8 →